Have Beta Bionics Insiders Been Selling Stock?

Anyone interested in Beta Bionics, Inc. (NASDAQ:BBNX) should probably be aware that the President, Sean Saint, recently divested US$213k worth of shares in the company, at an average price of US$12.61 each. However, the silver lining is that the sale only reduced their total holding by 3.9%, so we're hesitant to read anything much into it, on its own.

Advertisement

The Last 12 Months Of Insider Transactions At Beta Bionics

Notably, that recent sale by Sean Saint is the biggest insider sale of Beta Bionics shares that we've seen in the last year. That means that even when the share price was below the current price of US$13.89, an insider wanted to cash in some shares. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 3.9% of Sean Saint's holding.

Insiders in Beta Bionics didn't buy any shares in the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

View our latest analysis for Beta Bionics

insider-trading-volume
NasdaqGM:BBNX Insider Trading Volume June 5th 2026

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Does Beta Bionics Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 5.6% of Beta Bionics shares, worth about US$31m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Beta Bionics Insider Transactions Indicate?

Insiders sold stock recently, but they haven't been buying. And even if we look at the last year, we didn't see any purchases. Insiders own shares, but we're still pretty cautious, given the history of sales. We're in no rush to buy! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Every company has risks, and we've spotted 3 warning signs for Beta Bionics you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Valuation is complex, but we're here to simplify it.

Discover if Beta Bionics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGM:BBNX

Beta Bionics

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.

Flawless balance sheet with low risk.

Advertisement

Weekly Picks

LO
Lou_Basenese
VTIX logo
Lou_Basenese on Virtuix Holdings ·

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Fair Value:US$7.557.6% undervalued
17 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.8% undervalued
63 users have followed this narrative
1 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56054.5% undervalued
61 users have followed this narrative
4 users have commented on this narrative
29 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2781.6% undervalued
33 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

AN
AntonioS
CAR logo
AntonioS on CAR Group ·

CAR Group. A wonderful compounding franchise at a fair-not-cheap price.

Fair Value:AU$3219.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GA
PLTR logo
GaryB on Palantir Technologies ·

Palantir hits 52 week low.

Fair Value:US$274.861.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NO
EWY logo
North49_ on iShares - iShares MSCI South Korea ETF ·

EWY:US NYSE Arca iShares Msci South Korea ETF, an opportunity to diversify your tech investments.

Fair Value:US$273.4525.0% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9639.6% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7445.2% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.8% undervalued
63 users have followed this narrative
1 users have commented on this narrative
7 users have liked this narrative